Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Landscape of Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired RET Fusion.

Piotrowska Z, Isozaki H, Lennerz JK, Gainor JF, Lennes IT, Zhu VW, Marcoux N, Banwait MK, Digumarthy SR, Su W, Yoda S, Riley AK, Nangia V, Lin JJ, Nagy RJ, Lanman RB, Dias-Santagata D, Mino-Kenudson M, Iafrate AJ, Heist RS, Shaw AT, Evans EK, Clifford C, Ou SI, Wolf B, Hata AN, Sequist LV.

Cancer Discov. 2018 Dec;8(12):1529-1539. doi: 10.1158/2159-8290.CD-18-1022. Epub 2018 Sep 26.

PMID:
30257958
2.

Targeting kinases with precision.

Gardino AK, Evans EK, Kim JL, Brooijmans N, Hodous BL, Wolf B, Lengauer C.

Mol Cell Oncol. 2018 Apr 11;5(3):e1435183. doi: 10.1080/23723556.2018.1435183. eCollection 2018.

PMID:
30250891
3.

Precision Targeted Therapy with BLU-667 for RET-Driven Cancers.

Subbiah V, Gainor JF, Rahal R, Brubaker JD, Kim JL, Maynard M, Hu W, Cao Q, Sheets MP, Wilson D, Wilson KJ, DiPietro L, Fleming P, Palmer M, Hu MI, Wirth L, Brose MS, Ou SI, Taylor M, Garralda E, Miller S, Wolf B, Lengauer C, Guzi T, Evans EK.

Cancer Discov. 2018 Jul;8(7):836-849. doi: 10.1158/2159-8290.CD-18-0338. Epub 2018 Apr 15.

PMID:
29657135
4.

A precision therapy against cancers driven by KIT/PDGFRA mutations.

Evans EK, Gardino AK, Kim JL, Hodous BL, Shutes A, Davis A, Zhu XJ, Schmidt-Kittler O, Wilson D, Wilson K, DiPietro L, Zhang Y, Brooijmans N, LaBranche TP, Wozniak A, Gebreyohannes YK, Schöffski P, Heinrich MC, DeAngelo DJ, Miller S, Wolf B, Kohl N, Guzi T, Lydon N, Boral A, Lengauer C.

Sci Transl Med. 2017 Nov 1;9(414). pii: eaao1690. doi: 10.1126/scitranslmed.aao1690.

PMID:
29093181
5.

Weight compensation characteristics of Armeo®Spring exoskeleton: implications for clinical practice and research.

Perry BE, Evans EK, Stokic DS.

J Neuroeng Rehabil. 2017 Feb 17;14(1):14. doi: 10.1186/s12984-017-0227-0.

6.

Health insurance: give the gift of choice. Healthcare reform's impact on your practice. Part 3.

Evans EK.

Del Med J. 2014 Jan;86(1):25-6. No abstract available.

PMID:
24716388
7.

Health care reform's impact on your organization. Part 2.

Evans EK.

Del Med J. 2013 Dec;85(12):377-8. No abstract available.

PMID:
24654359
8.

Health care reform's impact on your organization. Part 1.

Evans EK.

Del Med J. 2013 Nov;85(11):345-6. Review. No abstract available.

PMID:
24649630
9.

Inhibition of Btk with CC-292 provides early pharmacodynamic assessment of activity in mice and humans.

Evans EK, Tester R, Aslanian S, Karp R, Sheets M, Labenski MT, Witowski SR, Lounsbury H, Chaturvedi P, Mazdiyasni H, Zhu Z, Nacht M, Freed MI, Petter RC, Dubrovskiy A, Singh J, Westlin WF.

J Pharmacol Exp Ther. 2013 Aug;346(2):219-28. doi: 10.1124/jpet.113.203489. Epub 2013 May 24.

10.

Analysis of apoptosis using Xenopus egg extracts.

Kornbluth S, Evans EK.

Curr Protoc Cell Biol. 2001 May;Chapter 11:Unit 11.12. doi: 10.1002/0471143030.cb1112s09.

PMID:
18228303
11.

Preparation and use of interphase Xenopus egg extracts.

Powers M, Evans EK, Yang J, Kornbluth S.

Curr Protoc Cell Biol. 2001 May;Chapter 11:Unit 11.10. doi: 10.1002/0471143030.cb1110s09.

PMID:
18228302
12.

Potential autoregulation of transcription factor PU.1 by an upstream regulatory element.

Okuno Y, Huang G, Rosenbauer F, Evans EK, Radomska HS, Iwasaki H, Akashi K, Moreau-Gachelin F, Li Y, Zhang P, Göttgens B, Tenen DG.

Mol Cell Biol. 2005 Apr;25(7):2832-45.

13.

The amino terminal and E2F interaction domains are critical for C/EBP alpha-mediated induction of granulopoietic development of hematopoietic cells.

D'Alo' F, Johansen LM, Nelson EA, Radomska HS, Evans EK, Zhang P, Nerlov C, Tenen DG.

Blood. 2003 Nov 1;102(9):3163-71. Epub 2003 Jul 17.

14.

COBRA: who must comply?

Evans EK.

Del Med J. 2001 Nov;73(11):429-30. No abstract available.

PMID:
11725462
15.

Wee1-regulated apoptosis mediated by the crk adaptor protein in Xenopus egg extracts.

Smith JJ, Evans EK, Murakami M, Moyer MB, Moseley MA, Vande Woude G, Kornbluth S.

J Cell Biol. 2000 Dec 25;151(7):1391-400.

16.

Reaper-induced dissociation of a Scythe-sequestered cytochrome c-releasing activity.

Thress K, Evans EK, Kornbluth S.

EMBO J. 1999 Oct 15;18(20):5486-93.

17.

Regulation of apoptosis in Xenopus egg extracts.

Evans EK, Kornbluth S.

Adv Enzyme Regul. 1998;38:265-80. No abstract available.

PMID:
9762358
18.

Reaper-induced apoptosis in a vertebrate system.

Evans EK, Kuwana T, Strum SL, Smith JJ, Newmeyer DD, Kornbluth S.

EMBO J. 1997 Dec 15;16(24):7372-81.

19.

Crk is required for apoptosis in Xenopus egg extracts.

Evans EK, Lu W, Strum SL, Mayer BJ, Kornbluth S.

EMBO J. 1997 Jan 15;16(2):230-41.

Supplemental Content

Loading ...
Support Center